Assessment of neuroinflammation in a mouse model of obesity and β-amyloidosis using PET

Abstract

BackgroundObesity has been identified as a risk factor for cognitive decline and Alzheimer’s disease (AD). The aim of this study was to investigate the effect of obesity on neuroinflammation and cerebral glucose metabolism using PET in a mouse model of β-amyloidosis and determine the relationship between these PET imaging biomarkers, pathogenic changes, and functional outcomes.MethodsThree-month-old C57BL/J6 mice were fed either a standard (control group) or high-fat diet (obese group) for 3 months and intracerebroventricularly infused with vehicle or human beta amyloid 1-42 (Aβ42). We assessed obesity-induced abnormalities in peripheral metabolic indices including adiposity, fasting glucose, and glucose tolerance. Brain glucose metabolism was assessed by 18F-FDG PET, and glial activation was assessed using the translocator protein (TSPO) ligand 11C-PBR-28. TSPO expression was confirmed by immunohistochemistry of brain sections obtained from scanned mice. The association between inflammatory state and 11C-PBR-28 PET signals was characterized by examination of the cytokine expression profile in both the serum and hippocampus by antibody array. Learning and memory performance was assessed in the object recognition task, and anxiety-related behavior was assessed in the elevated plus maze.ResultsObesity combined with Aβ infusion promoted neuroinflammation and cerebral hypermetabolism, and these signals were significant predictors of learning and memory performance in the object recognition task. In vivo TSPO signals were associated with inflammatory markers including CXCL1, CXCL2, CXCL12, CCL3, CCL5, TIMP-1, G-CSF, sICAM-1, and IL-1ra.ConclusionsIn vivo cerebral metabolism and TSPO signals indicate that obesity can accelerate amyloid-induced inflammation and associated cognitive decline.

CNS and systemic inflammation underlying neuropsychiatric symptoms and related cognitive decline in older people.

“…The strong association of sICAM-1 with the volume of the hippocampus and 3 rd ventricle (re ecting atrophy of surrounding areas) suggests these regions may play a role in the pathogenesis of NPS, although we cannot exclude sICAM-1 is linked to NPS via mechanisms independent of atrophy. Interestingly, these regions have been associated with the progression of AD pathology and in ammation in previous work (46,47). Considering our observations and previous reports (13), we infer that decreased volume of the hippocampus and increased 3 rd ventricle volume may indicate regional neurodegeneration and neuroin ammation together involved in the pathogenesis of NPS of the symptoms associated with sICAM-1 (i.e.…”

Hypoxic-Inflammatory Responses under Acute Hypoxia: In Vitro Experiments and Prospective Observational Expedition Trial

“…In this regard, in a next step, we analyzed chemoattractant receptor CXCR-4, and its ligand SDF-1. CXCR-4 plays an important role in target-oriented migration of stem and immune cells towards the site of infection, while recent studies even propose an association with neuroinflammation [32,33,41]. This is of particular interest as CXCR-4 and its ligand SDF-1 are the key elements regulating the entrance of lymphocytes to the central nervous system [42].…”

Cognitive and behavioral evaluation of nutritional interventions in rodent models of brain aging and dementia

“… 93 In another study, a 3-month HFD period significantly increased the proinflammatory cytokine profile in mice and impaired NOR test performance. 94 A chronic HFD results in impaired short- and long-term memory in mice as measured by NOR and MWM, possibly due in part to impaired hippocampal insulin signaling. CR can attenuate the adverse effects of a HFD on cognition.…”